Literature DB >> 10534167

Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract.

M Li1, L A Cannizzaro.   

Abstract

One of the most important biological features of papillary transitional cell carcinoma (pTCC) of the urinary tract is its multicentricity and its tendency for recurrences. Two possible mechanisms, field effect and intramucosal seeding/spreading, have been proposed. The former theory hypothesizes that carcinogenic agents cause synchronous or metachronous malignant transformation of multiple urothelial cells (independent clonal origin), and the latter speculates that synchronous and metachronous tumors are derived from implantation or direct spreading of tumor cells (identical clonal origin). We tested these hypotheses by analyzing the methylation patterns of the androgen receptor gene (HUMARA) located at the X-chromosome. Thirty-five metachronous and synchronous, low-grade (grade 1 or 2), noninvasive pTCCs of the urinary tract from 10 heterozygous female patients were successfully analyzed using formalin-fixed, paraffin-embedded tissue. These included 16 recurrent bladder tumors from 4 patients, 10 metachronous bladder and ureter/renal pelvis tumors from 4 patients, and 9 multifocal tumors from 2 patients. All tumors are monoclonal as indicated by unbalanced methylation of HUMARA. Furthermore, same methylated allele was detected in multiple recurrent or multifocal tumors from any given patient, indicating their identical clonal origin. We conclude that low-grade, noninvasive pTCCs are monoclonal in nature. Synchronous or metachronous pTCCs have an identical clonal origin, strongly supporting the intramucosal seeding/spreading hypothesis.

Entities:  

Mesh:

Year:  1999        PMID: 10534167     DOI: 10.1016/s0046-8177(99)90037-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Non-invasive papillary urothelial carcinoma of the vagina: molecular analysis of a rare case identifies clonal relationship to non-invasive urothelial carcinoma of the bladder.

Authors:  Hind N Warzecha; Falko Fend; Julia Steinhilber; Harald Abele; Melanie Henes; Niklas Harland; Annette Staebler
Journal:  Virchows Arch       Date:  2017-06-07       Impact factor: 4.064

Review 2.  [Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series].

Authors:  J Hatina; W Huckenbeck; H Rieder; H-H Seifert; W A Schulz
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

3.  Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants.

Authors:  Laura Ardighieri; Felix Zeppernick; Charlotte G Hannibal; Russell Vang; Leslie Cope; Jette Junge; Susanne K Kjaer; Robert J Kurman; Ie-Ming Shih
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

4.  Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy.

Authors:  Michael A Moriarty; Matthew A Uhlman; Megan T Bing; Michael A O'Donnell; James A Brown; Chad R Tracy; Sundeep Deorah; Kenneth G Nepple; Amit Gupta
Journal:  BMC Urol       Date:  2015-05-28       Impact factor: 2.264

5.  Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.

Authors:  Tadao Nakazawa; Tetsuo Kondo; Ippei Tahara; Kazunari Kasai; Tomohiro Inoue; Naoki Oishi; Kunio Mochizuki; Takeo Kubota; Ryohei Katoh
Journal:  Cancer Med       Date:  2015-04-17       Impact factor: 4.452

6.  Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.

Authors:  Christoffer Wennersten; Gustav Andersson; Karolina Boman; Björn Nodin; Alexander Gaber; Karin Jirström
Journal:  Diagn Pathol       Date:  2014-10-03       Impact factor: 2.644

7.  Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Che-Yuan Hu; Yu-Chieh Tsai; Shuo-Meng Wang; Chao-Yuan Huang; Huai-Ching Tai; Chung-Hsin Chen; Yeong-Shiau Pu; Wei-Chou Lin; Kuo-How Huang
Journal:  Biomed Res Int       Date:  2015-03-31       Impact factor: 3.411

8.  Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma.

Authors:  Reza Gheitasi; Esmaeil Sadeghi; Mohammad Jafari
Journal:  Iran J Pathol       Date:  2020-11-13

9.  Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.

Authors:  H Kawanishi; T Takahashi; M Ito; Y Matsui; J Watanabe; N Ito; T Kamoto; T Kadowaki; G Tsujimoto; I Imoto; J Inazawa; H Nishiyama; O Ogawa
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640

10.  Recurrent and multiple bladder tumors show conserved expression profiles.

Authors:  David Lindgren; Sigurdur Gudjonsson; Kowan Ja Jee; Fredrik Liedberg; Sonja Aits; Anna Andersson; Gunilla Chebil; Ake Borg; Sakari Knuutila; Thoas Fioretos; Wiking Månsson; Mattias Höglund
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.